Ocugen, Inc. revenue breakdown overview

Ocugen, Inc. revenue for the last year amounted to 3.00 M USD, the most of which — 6.04 M USD — came from its highest performing source at the moment, Novel Gene and Cell Therapies and Vaccines, the year earlier bringing 42.62 k USD. The greatest contribution to the revenue figure was made by United States — last year it brought Ocugen, Inc. 6.04 M USD, and the year before that — 42.62 k USD.